BioRestorative Therapies (BRTX) to Release Earnings on Friday

BioRestorative Therapies (NASDAQ:BRTX) is anticipated to announce its earnings results before the market opens on Friday, April 4th. Analysts expect the company to announce earnings of ($0.27) per share and revenue of $0.48 million for the quarter.

BioRestorative Therapies Trading Up 4.0 %

NASDAQ BRTX opened at $1.83 on Friday. The stock has a market capitalization of $12.66 million, a price-to-earnings ratio of -1.20 and a beta of 64.37. The stock has a 50-day moving average of $1.97 and a 200 day moving average of $1.72. BioRestorative Therapies has a twelve month low of $1.03 and a twelve month high of $2.55.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.